BIO-LOGICAL ZINC SOLUTION Australia - inglés - Department of Health (Therapeutic Goods Administration)

bio-logical zinc solution

orthomolecular medisearch laboratories pty ltd trading as biological therapies - zinc sulfate heptahydrate -

LIFE LINCO-SPEC PREMIX Malasia - inglés - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

life linco-spec premix

life biopharma sdn. bhd. - lincomycin hydrochloride (monohydrate); spectinomycin sulfate (tetrahydrate) -

FOLINZ TABLETS Kenia - inglés - Pharmacy and Poisons Board

folinz tablets

apex laboratories private limited sidco garment complex iii floor,guindy 600032, - zinc sulfate and folic acid tablets - tablet - folic acid bp 5mg zinc sulfate monohydrate usp… - antianemic preparations - vitamin b12 and folic

KEPIVANCE- palifermin injection, powder, lyophilized, for solution Estados Unidos - inglés - NLM (National Library of Medicine)

kepivance- palifermin injection, powder, lyophilized, for solution

swedish orphan biovitrum ab (publ) - palifermin (unii: qms40680k6) (palifermin - unii:qms40680k6) - palifermin 6.25 mg in 1.2 ml - kepivance is indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support. kepivance is indicated as supportive care for preparative regimens predicted to result in ≥ who grade 3 mucositis in the majority of patients. kepivance is a mucocutaneous epithelial human growth factor indicated to decrease the incidence and duration of severe oral mucositis in patients with hematologic malignancies receiving myelotoxic therapy in the setting of autologous hematopoietic stem cell support. kepivance is indicated as supportive care for preparative regimens predicted to result in ≥ who grade 3 mucositis in the majority of patients. the safety and efficacy of kepivance have not been established in patients with non-hematologic malignancies )]. the safety and efficacy of kepivance have not been established in patients with non-hematologic malignancies